Clinical trial
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for the Treatment of Relapsing-Remitting Multiple Sclerosis
NCT03535298 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for the Treatment of Relapsing-Remitting Multiple Sclerosis
- Lead sponsor
- The Cleveland Clinic
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- January 3, 2019
- Completion date
- July 30, 2027
- Enrollment
- 800 (estimated)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.